Key result
EVT plus medical management shows no significant long-term rCBF trajectory benefit over medical management alone.
Why the study?
Hemodynamic compromise contributes to stroke recurrence in severe symptomatic intracranial atherosclerotic stenosis, motivating a characterization of longitudinal CT perfusion changes under endovascular treatment versus medical management.
Does endovascular treatment plus medical management improve longitudinal CT perfusion deficit trajectories compared to medical management alone in patients with severe symptomatic intracranial atherosclerotic stenosis?
Cohort (n=102)
Does endovascular treatment plus medical management improve longitudinal CT perfusion deficit trajectories compared to medical management alone in patients with severe symptomatic intracranial atherosclerotic stenosis?
In patients with severe symptomatic intracranial atherosclerotic stenosis, endovascular treatment was associated with stabilized cerebral perfusion deficits compared to expansion under medical management in adjusted models, though differences were not significant after propensity score overlap weighting.
Answers are grounded in this paper and cite their sources.
Endovascular treatment shows no significant rCBF benefit after overlap weighting; leaves open its role in symptomatic intracranial atherosclerotic stenosis.
Hemodynamic compromise plays an important role in stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis (sICAS). We aimed to characterize longitudinal CT perfusion (CTP) changes in patients with severe sICAS managed with endovascular treatment (EVT) or medical management (MM). This retrospective cohort study included patients with severe sICAS (70%-99% stenosis) and recent ischemic stroke (<3 months) identified from a CTP database. Patients were grouped according to treatment received: MM alone or EVT plus MM. Baseline and follow-up CTP examinations were obtained at least 5 months apart. Changes in perfusion deficit volumes defined by relative cerebral blood flow (rCBF) and time-to-maximum (Tmax) thresholds were evaluated using adjusted longitudinal models. Propensity score overlap-weighted generalized estimating equation models were used for sensitivity analyses. Clinical events were recorded descriptively. Among 102 patients (44 MM; 58 EVT), perfusion deficit volumes defined by rCBF < 38% and < 34% significantly expanded in the MM group (both P = 0.018), whereas the EVT group showed no significant change. Primary adjusted analyses showed significant treatment-by-time interactions for rCBF < 38% and < 34% (both interaction P = 0.021). Overlap-weighted estimates remained directionally consistent but were not statistically significant (P = 0.162 and P = 0.160, respectively). The 1-year rates of target-territory recurrent ischemic stroke were 9.1% with MM and 8.6% with EVT. Primary adjusted analyses suggested different longitudinal rCBF trajectories between groups, but these differences were not statistically significant after overlap weighting. These findings should be considered exploratory and require confirmation in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) conducted a cohort in Severe symptomatic intracranial atherosclerotic stenosis (sICAS) (n=102). Endovascular treatment (EVT) plus medical management (MM) vs. Medical management (MM) alone was evaluated on Longitudinal changes in CT perfusion deficit volumes defined by relative cerebral blood flow (rCBF <38% and <34%) and time-to-maximum (Tmax) thresholds (p=0.021). Endovascular treatment plus medical management showed different rCBF trajectories vs medical management, but differences were non-significant after overlap weighting.
Synapse has enriched 10 related papers. Consider them for comparative context: